Loading chart…
PRE-MARKET
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel, capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, ophthalmic droppers, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags.
Caplin Point Laboratories Limited (CAPLIPOINT) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The CAPLIPOINT share price is ₹2,457.20 (+1.48% today), with a market capitalisation of ₹187B and a price-to-earnings (P/E) ratio of 28.2. MarketRipple tracks the CAPLIPOINT investment thesis, the ripple-chain impact of market events on Caplin Point Laboratories Limited, and the Healthcare sector outlook.
Open
₹2,397.00
High
₹2,485.00
Low
₹2,391.20
Prev. Close
₹2,421.40
52W High
₹2,990.00
52W Low
₹1,500.30
Day range
₹2,391.20–₹2,485.00
52-week range
₹1,500.30–₹2,990.00
Volume
19K
P/E
28.2
ROE
17.9%
D/E
0.00
Margin
29.1%
Caplin Point Laboratories Limited (NSE: CAPLIPOINT) is currently trading at ₹2,457.20 (+1.48%).
Caplin Point Laboratories Limited's market capitalization is ₹187B.
Caplin Point Laboratories Limited's price-to-earnings (P/E) ratio is 28.2.
Caplin Point Laboratories Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Caplin Point Laboratories Limited currently reads neutral, based on 2 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.